Macrobid vs. Flagyl
See how Macrobid and Flagyl compare on approved uses, dosing, side effects, and cost.
Key Takeaways
Macrobid is a urinary anti-infective used specifically for uncomplicated bladder infections, while Flagyl treats anaerobic bacterial infections and certain parasitic infections like trichomoniasis.
Macrobid concentrates in urine and has little effect elsewhere in the body, so it cannot treat infections outside the urinary tract, unlike Flagyl.
Flagyl requires strict alcohol avoidance and carries a boxed warning about cancer risk seen in animal studies, warnings Macrobid does not carry.
Macrobid vs. Flagyl Drug Summary
Macrobid
Macrobid (nitrofurantoin) is a urinary anti-infective that treats acute, uncomplicated bladder infections caused by susceptible bacteria like E. coli. It is taken as an oral capsule, usually twice a day for seven days, and works by concentrating in the urine rather than the bloodstream.
Flagyl
Flagyl (metronidazole) is a nitroimidazole antimicrobial that treats anaerobic bacterial infections, amebiasis, and trichomoniasis. It is taken as an oral tablet, with dosing and duration that vary widely depending on which infection it is treating.
Macrobid vs. Flagyl Side Effects
Macrobid
Flagyl
Macrobid vs. Flagyl Dosage
Macrobid
Flagyl
| STAGE | DOSE | WHEN |
| Starting dose | 100 mg every 12 hours | Days 1-7 |
| Maximum dose | 100 mg every 12 hours | Same as starting |
| Dose changes | None | Fixed dose |
| STAGE | DOSE | WHEN |
| Starting dose | 250 mg three times daily | Days 1-7 |
| Maximum dose | 7.5 mg/kg every 6 hours | Days 1-7 |
| Dose changes | 3 increases | As tolerated |
Macrobid
| STAGE | DOSE | WHEN |
| Starting dose | 100 mg every 12 hours | Days 1-7 |
| Maximum dose | 100 mg every 12 hours | Same as starting |
| Dose changes | None | Fixed dose |
Flagyl
| STAGE | DOSE | WHEN |
| Starting dose | 250 mg three times daily | Days 1-7 |
| Maximum dose | 7.5 mg/kg every 6 hours | Days 1-7 |
| Dose changes | 3 increases | As tolerated |
Macrobid vs. Flagyl Indications
Macrobid
Macrobid is FDA-approved for acute, uncomplicated urinary tract infections caused by susceptible bacteria such as E. coli. It is also commonly used off-label at lower doses for long-term prevention of recurrent UTIs.
Acute uncomplicated UTI (cystitis) from E. coli or S. saprophyticus
Off-label: low-dose prophylaxis for recurrent UTIs
Not approved for pyelonephritis or upper urinary tract infections
Not approved for children under 12 or infants under 1 month
Contraindicated near labor and delivery at term
Flagyl
Flagyl is FDA-approved for trichomoniasis, amebiasis, and anaerobic bacterial infections throughout the body. It is also used off-label, in a specific dosing regimen, for bacterial vaginosis.
Symptomatic and asymptomatic trichomoniasis
Treatment of sexual partners of trichomoniasis patients
Amebiasis (intestinal and extraintestinal)
Anaerobic bacterial infections
Off-label: bacterial vaginosis
Macrobid vs. Flagyl Pros and Cons
Macrobid
Macrobid stays concentrated in the urine, which limits its systemic side effects but also limits it strictly to bladder infections. It has been a reliable UTI treatment for decades, though it requires normal kidney function to work safely.
Pros
Reliably effective against E. coli even after decades of use
Simple twice-daily course for just seven days
Minimal systemic drug levels reduce some whole-body side effect risks
No alcohol restriction like Flagyl requires
Cons
Contraindicated in significant kidney impairment
Cannot treat infections outside the urinary tract
Long-term use linked to rare but serious lung and liver reactions
Not approved for children under 12
Flagyl
Flagyl covers a much broader range of infections than Macrobid, including anaerobic bacteria and certain parasites, and offers a convenient single-dose option for trichomoniasis. That breadth comes with a boxed cancer warning and a strict requirement to avoid alcohol during treatment.
Pros
Treats anaerobic infections throughout the body, not just the urinary tract
Single-dose option available for trichomoniasis
Decades of established use across many infection types
Available in oral, IV, and extended-release forms for different severities
Cons
Boxed warning for carcinogenicity seen in animal studies
Must avoid alcohol during and after treatment due to severe reactions
Contraindicated in patients with Cockayne syndrome
Brand-name tablets are discontinued, so only generic is available
Common Symptoms and Related Diseases You Can Explore
Explore a range of common symptoms the Doctronic Symptom Checker can help you understand.